# Opioid Antagonism in Individuals Ascertained Through the Partners HealthCare Biobank

> **NCT04975347** · PHASE1 · COMPLETED · sponsor: **Stephanie B. Seminara, MD** · enrollment: 47 (actual)

## Conditions studied

- Reproductive Disorders

## Interventions

- **DRUG:** Naloxone

## Key facts

- **NCT ID:** NCT04975347
- **Lead sponsor:** Stephanie B. Seminara, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-03
- **Primary completion:** 2025-08-08
- **Final completion:** 2025-08-08
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2026-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04975347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04975347, "Opioid Antagonism in Individuals Ascertained Through the Partners HealthCare Biobank". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04975347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*